Registrera dig | Logga in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuhs arb [63 articles]

Senaste hänvisningarna i jyuhs bibliotek insorterade under taggen arb. You can also see everyone's arb.
  • Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy.
    Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 31, No. 6. (June 2008), pp. 1147-1155.
    by S Ogawa, T Mori, K Nako, S Ito
    posted to dn ccb arb acei by jyuh on 2008-09-07 06:06:49 as **
  • Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: Evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
    Nephrology (Carlton, Vic.) (17 March 2008)
    by Shuichi Ohtomo, Masaki Ito, Yuko Izuhara, Charles van Ypersele de Strihou, Toshio Miyata
    posted to arb dn mouse by jyuh on 2008-08-30 06:38:40 as **
  • Uricosuric Action of Losartan via the Inhibition of Urate Transporter 1 (URAT 1) in Hypertensive Patients.
    American journal of hypertension : journal of the American Society of Hypertension (31 July 2008)
    by Toshihiro Hamada, Kimiyoshi Ichida, Makoto Hosoyamada, Einosuke Mizuta, Kiyotaka Yanagihara, Kazuhiko Sonoyama, Shinobu Sugihara, Osamu Igawa, Tatsuo Hosoya, Akira Ohtahara, Chiaki Shigamasa, Yasutaka Yamamoto, Haruaki Ninomiya, Ichiro Hisatome
    posted to arb bp urate urate-transporter by jyuh on 2008-08-12 04:49:36 as **
  • Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (22 July 2008)
    by Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara, Naofumi Ikeda, Junko Shoda, Tsuneo Takenaka, Tsutomu Inoue, Ryuichiro Araki
    posted to arb cv hd rct by jyuh on 2008-08-06 09:19:29 as **
  • Angiotensin Receptor Blockers: Current Status and Future Prospects
    The American Journal of Medicine, Vol. 121, No. 8. (August 2008), pp. 656-663.
    by Ram
    posted to arb rct by jyuh on 2008-08-06 08:42:27 as **
  • Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, Vol. 9, No. 1. (March 2008), pp. 1-9.
    by B Gojanovic, F Feihl, L Liaudet, B Waeber
    posted to acei arb bp ccb by jyuh on 2008-07-21 05:49:29 as **
  • Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    The American journal of cardiology, Vol. 100, No. 3A. (6 August 2007)
    by M Böhm
    posted to acei arb cv dual rct by jyuh on 2008-07-21 05:03:00 as **
  • The COOPERATE trial: a letter of concern.
    Lancet, Vol. 371, No. 9624. (10 May 2008), pp. 1575-1576.
    by R Kunz, M Wolbers, T Glass, JF Mann
    posted to acei arb meta-analysis rct by jyuh on 2008-07-21 05:00:41 as **
  • Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
    Lancet, Vol. 361, No. 9352. (11 January 2003), pp. 117-124.
    by N Nakao, A Yoshimura, H Morita, M Takada, T Kayano, T Ideura
    posted to acei arb ckd dual rct by jyuh on 2008-07-21 04:47:08 as **
  • Sex differences in response to chronic heart failure therapies
    Expert Review of Cardiovascular Therapy, Vol. 6, No. 4. (April 2008), pp. 555-565.
    by Ghali, K Jalal, Lindenfeld, Joann
    posted to acei arb chf gender by jyuh on 2008-07-21 04:39:52 as **
  • Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy.
    Vascular health and risk management, Vol. 4, No. 1. (2008), pp. 223-234.
    by GL Colombo, M Caruggi, C Ottolini, AP Maggioni
    posted to acei arb cost-effective dual rct by jyuh on 2008-07-21 04:19:24 as **
  • Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163.
    by RA Weir, JJ McMurray, M Puu, SD Solomon, B Olofsson, CB Granger, S Yusuf, EL Michelson, K Swedberg, MA Pfeffer,
    posted to acei arb chf dual rct by jyuh on 2008-07-21 04:10:12 as **
  • Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Circulation, Vol. 115, No. 24. (19 June 2007), pp. 3111-3120.
    by E O'Meara, T Clayton, MB McEntegart, JJ McMurray, IL Piña, CB Granger, J Ostergren, EL Michelson, SD Solomon, S Pocock, S Yusuf, K Swedberg, MA Pfeffer,
    posted to arb chf gender rct by jyuh on 2008-07-21 04:09:11 as **
  • Angiotensin II receptor blockers for the treatment of heart failure: a class effect?
    Pharmacotherapy, Vol. 27, No. 4. (April 2007), pp. 526-534.
    by M Hudson, K Humphries, JV Tu, H Behlouli, R Sheppard, L Pilote
    posted to arb chf by jyuh on 2008-07-21 03:14:42 as **
  • Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 602-609.
    by M Hudson, E Rahme, H Behlouli, R Sheppard, L Pilote
    posted to acei arb chf gender by jyuh on 2008-07-21 03:13:15 as **
  • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
    Journal of hypertension, Vol. 25, No. 5. (May 2007), pp. 951-958.
    by , F Turnbull, B Neal, M Pfeffer, J Kostis, C Algert, M Woodward, J Chalmers, A Zanchetti, S MacMahon
    posted to acei arb bp cv by jyuh on 2008-07-21 02:08:23 as **
  • Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by T Unger, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to acei arb dual by jyuh on 2008-07-21 02:01:04 as **
  • No HOPE without proof: do ARBs meet the standard for cardiovascular protection?
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by P Sleight, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to arb cv by jyuh on 2008-07-21 02:00:45 as **
  • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Journal of hypertension, Vol. 26, No. 7. (July 2008), pp. 1282-1289.
    by Gianpaolo Reboldi, Fabio Angeli, Claudio Cavallini, Giorgio Gentile, Giuseppe Mancia, Paolo Verdecchia
    posted to acei arb cv meta-analysis mortality stroke by jyuh on 2008-07-21 01:49:35 as **
  • Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers. Potential Multipronged Strategy in Stroke Prevention.
    Cerebrovascular diseases (Basel, Switzerland), Vol. 26, No. 2. (17 June 2008), pp. 106-112.
    by Amytis Towfighi, Bruce Ovbiagele
    posted to arb ppar stroke by jyuh on 2008-07-21 01:47:26 as **
  • Reduction of proteinuria with angiotensin receptor blockers.
    Nature clinical practice. Cardiovascular medicine, Vol. 5 Suppl 1 (July 2008)
    by J Galle
    posted to arb proteinuria by jyuh on 2008-07-20 16:00:45 as **
  • Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.
    The Canadian journal of cardiology, Vol. 24, No. 6. (June 2008), pp. 491-496.
    by DM Rabi, N Khan, M Vallee, MA Hladunewich, SW Tobe, L Pilote
    posted to acei arb gender rct by jyuh on 2008-07-20 15:56:27 as **
  • RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
    Clinical research in cardiology : official journal of the German Cardiac Society, Vol. 97, No. 7. (July 2008), pp. 418-431.
    by C Werner, M Baumhäkel, KK Teo, R Schmieder, J Mann, T Unger, S Yusuf, M Böhm
    posted to acei arb dual by jyuh on 2008-07-20 15:55:07 as **
  • Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Postgraduate medicine, Vol. 120, No. 1. (April 2008), pp. 33-42.
    by GL Bakris, MR Weir
    posted to acei arb ckd dual by jyuh on 2008-07-20 15:17:06 as **
  • Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Journal of cardiac failure, Vol. 14, No. 3. (April 2008), pp. 181-188.
    by R Lakhdar, MH Al-Mallah, DE Lanfear
    posted to acei arb cv dual meta-analysis by jyuh on 2008-07-20 15:06:28 as **
  • Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide
    International Journal of Clinical Practice, Vol. 61, No. 12. (December 2007), pp. 2093-2102.
    by Flack,
    posted to arb diuretics by jyuh on 2008-07-20 02:08:59 as **
  • Olmesartan medoxomil : a review of its use in the management of hypertension.
    Drugs, Vol. 68, No. 9. (2008), pp. 1239-1272.
    by LJ Scott, PL McCormack
    posted to arb by jyuh on 2008-07-19 16:59:24 as **
  • Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension.
    Drugs, Vol. 68, No. 9. (2008), pp. 1207-1225.
    by DH Smith
    posted to arb ht by jyuh on 2008-07-19 16:52:27 as **
  • Irbesartan : a review of its use in hypertension and diabetic nephropathy.
    Drugs, Vol. 68, No. 11. (2008), pp. 1543-1569.
    by KF Croom, GL Plosker
    posted to arb dn rct by jyuh on 2008-07-19 16:47:50 as **
  • Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
    Cancer, Vol. 112, No. 4. (15 February 2008), pp. 748-757.
    by R van der Knaap, C Siemes, JW Coebergh, CM van Duijn, A Hofman, BH Stricker
    posted to acei arb cancer by jyuh on 2008-07-14 11:32:31 as **
  • Effect of Pentoxifylline in Addition to Losartan on Proteinuria and GFR in CKD: A 12-Month Randomized Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (8 July 2008)
    by Shuei-Liong L Lin, Yung-Ming M Chen, Wen-Chih C Chiang, Kwan-Dun D Wu, Tun-Jun J Tsai
    posted to arb ckd pentoxifylline proteinuria by jyuh on 2008-07-14 04:53:16 as **
  • Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
    American journal of physiology. Renal physiology, Vol. 284, No. 4. (April 2003)
    by R Agarwal
    posted to acei arb ckd inflammation ros by jyuh on 2008-07-08 04:19:33 as **
  • Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.
    Journal of the American Society of Nephrology : JASN, Vol. 19, No. 5. (May 2008), pp. 999-1007.
    by L Vogt, F Waanders, F Boomsma, D de Zeeuw, G Navis
    posted to arb dn proteinuria by jyuh on 2008-07-05 03:25:19 as **
  • Effect of angiotensin II receptor blockers on insulin resistance in maintenance haemodialysis patients
    Nephrology, Vol. 12, No. 4. (August 2007), pp. 342-347.
    by Bancha Satirapoj, Pairoj Yingwatanadej, Somchai Chaichayanon, Jayanton Patumanond
    posted to arb hd irs by jyuh on 2008-07-04 11:35:14 as **
  • Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (20 June 2008)
    by Wei Fang, Dimitrios G G Oreopoulos, Joanne M M Bargman
    posted to acei arb mortality pd by jyuh on 2008-07-01 03:39:38 as **
  • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
    The New England journal of medicine, Vol. 345, No. 12. (20 September 2001), pp. 861-869.
    by BM Brenner, ME Cooper, D de Zeeuw, WF Keane, WE Mitch, HH Parving, G Remuzzi, SM Snapinn, Z Zhang, S Shahinfar,
    posted to arb dn rct by jyuh on 2008-06-14 07:13:32 as ** along with 1 person djmonstermo
  • Olmesartan reducing incidence of endstage renal disease in diabetic nephropathy trial (ORIENT): rationale and study design.
    Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 29, No. 9. (September 2006), pp. 703-709.
    by E Imai, S Ito, M Haneda, JC Chan, H Makino,
    posted to arb dn rct by jyuh on 2008-06-14 06:50:01 as **
  • Review: the renoprotective effects of ACE inhibitors and ARBs independent of blood pressure control are uncertain
    Evid Based Med, Vol. 11, No. 5. (1 October 2006), 145.
    by Catherine Clase, Amit X Garg
    posted to acei arb ckd by jyuh on 2008-06-12 05:36:34 as **
  • Molecule-specific Effects of Angiotensin II-Receptor Blockers Independent of the Renin-Angiotensin System.
    American journal of hypertension : journal of the American Society of Hypertension (5 June 2008)
    by Theodore W W Kurtz, Michal Pravenec
    posted to arb by jyuh on 2008-06-08 14:24:37 as **
  • Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
    Kidney international (21 May 2008)
    by George Bakris, Ellen Burgess, Matthew Weir, Giora Davidai, Stephen Koval
    posted to arb dn rct by jyuh on 2008-06-08 14:13:40 as **
  • Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (1 May 2008)
    by Jan Galle, Edzard Schwedhelm, Sabine Pinnetti, Rainer H H Böger, Christoph Wanner,
    posted to arb dn rct by jyuh on 2008-06-08 14:13:12 as **
  • Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    American heart journal, Vol. 155, No. 5. (May 2008), pp. 791-805.
    by S Balamuthusamy, L Srinivasan, M Verma, S Adigopula, N Jalandara, S Hathiwala, E Smith
    posted to acei arb ckd cv by jyuh on 2008-05-22 09:49:36 as **
  • Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression
    American Journal of Kidney Diseases, Vol. In Press, Corrected Proof
    by Fausta Catapano, Paolo Chiodini, Luca D Nicola, Roberto Minutolo, Pasquale Zamboli, Ciro Gallo, Giuseppe Conte
    posted to acei arb dual gn by jyuh on 2008-05-16 14:35:34 as **
  • Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers
    Nephrol. Dial. Transplant. (8 May 2008), gfn239.
    by Tomas Berl
    posted to acei arb ckd by jyuh on 2008-05-09 04:36:33 as **
  • Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (17 April 2008)
    by Leszek Tylicki, Przemysław Rutkowski, Marcin Renke, Wojciech Larczyński, Ewa Aleksandrowicz, Wiesława Lysiak-Szydlowska, Bolesław Rutkowski
    posted to acei arb ckd rct by jyuh on 2008-04-29 03:55:18 as **
  • Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, Vol. 27, No. 4. (g 2007), pp. 446-453.
    by I Kolesnyk, FW Dekker, M Noordzij, S le Cessie, DG Struijk, RT Krediet
    posted to acei arb pd by jyuh on 2008-04-17 10:27:43 as **
  • Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview.
    Hypertension, Vol. 50, No. 1. (July 2007), pp. 181-188.
    by JG Wang, Y Li, SS Franklin, M Safar
    posted to arb ccb cv by jyuh on 2008-04-15 03:00:34 as **
  • Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events.
    The New England journal of medicine (31 March 2008)
    by
    posted to acei arb cv dual rct by jyuh on 2008-04-14 03:34:40 as ** along with 2 people byrdjb djmonstermo
  • Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Eur J Endocrinol, Vol. 158, No. 3. (1 March 2008), pp. 317-322.
    by Gang Wang, Fernand M Lai, Ka-Bik Lai, Kai-Ming Chow, Bonnie C Kwan, Philip K Li, Cheuk-Chun Szeto
    posted to acei arb dn podocyte urine by jyuh on 2008-03-23 03:26:52 as **
  • Supratherapeutic Doses of Angiotensin Receptor Blockers to Decrease Proteinuria in Patients with Chronic Kidney Disease.
    Am J Nephrol, Vol. 28, No. 3. (7 December 2007), pp. 381-390.
    by Biff F F Palmer
    posted to arb ckd proteinuria by jyuh on 2008-02-14 09:43:47 as **
    • Du kan hänvisa till den här sidan som: http://www.citeulike.org/user/jyuh/tag/arb

    Result page: 1 2 Next RIS BibTeX